GHRP KP-102 Activates Specific Brain Neurons That Control Growth Hormone Release

The growth hormone-releasing peptide KP-102 activates neurons in the arcuate nucleus (a key GH-regulating brain area), and this effect persists even without the pituitary gland.

Kamegai, J et al.·Brain research. Molecular brain research·1996·Moderate EvidenceAnimal StudyAnimal Study
RPEP-00368Animal StudyModerate Evidence1996RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

KP-102 induces c-fos expression specifically in the arcuate nucleus, and this occurs even in hypophysectomized rats, confirming a direct hypothalamic site of action.

Key Numbers

How They Did This

Rat brains were processed for in situ hybridization of c-fos mRNA after systemic KP-102 administration. Both intact and hypophysectomized (pituitary-removed) adult male Wistar rats were tested.

Why This Research Matters

Proving GHRPs act directly on the hypothalamus (not just the pituitary) revealed a dual mechanism of action, explaining their potent GH-releasing effects and supporting combination therapy with GHRH.

The Bigger Picture

The arcuate nucleus finding helped explain why GHRPs and GHRH have synergistic effects — they work at different levels (hypothalamus vs. pituitary), supporting clinical combination protocols.

What This Study Doesn't Tell Us

Animal study with a specific GHRP variant (KP-102). The c-fos marker shows activation but doesn't reveal the functional consequence. Hypophysectomy creates an artificial state.

Questions This Raises

  • ?Do all GHRPs activate the same hypothalamic neurons?
  • ?Could targeting arcuate nucleus activation optimize GHRP-based GH therapies?

Trust & Context

Key Stat:
Direct brain action confirmed KP-102 activated arcuate nucleus neurons even in rats without pituitary glands, proving GHRPs act directly on the hypothalamus
Evidence Grade:
Moderate animal evidence using a well-validated neuronal activity marker. Hypophysectomy experiment provides strong mechanistic proof.
Study Age:
Published in 1996, this study helped establish the hypothalamic mechanism of GHRPs before the ghrelin receptor was fully characterized.
Original Title:
The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus.
Published In:
Brain research. Molecular brain research, 39(1-2), 153-9 (1996)
Database ID:
RPEP-00368

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is the arcuate nucleus?

The arcuate nucleus is a cluster of neurons at the base of the hypothalamus that serves as a master control center for growth hormone regulation, appetite, and metabolism. It contains the neurons that produce GHRH and somatostatin.

Why does it matter that GHRPs work on the brain?

If GHRPs only worked on the pituitary, they'd essentially duplicate GHRH's action. By also acting on the hypothalamus, GHRPs stimulate GH release through a completely separate pathway, which is why combining GHRPs with GHRH produces a synergistic effect greater than either alone.

Read More on RethinkPeptides

Cite This Study

RPEP-00368·https://rethinkpeptides.com/research/RPEP-00368

APA

Kamegai, J; Hasegawa, O; Minami, S; Sugihara, H; Wakabayashi, I. (1996). The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus.. Brain research. Molecular brain research, 39(1-2), 153-9.

MLA

Kamegai, J, et al. "The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus.." Brain research. Molecular brain research, 1996.

RethinkPeptides

RethinkPeptides Research Database. "The growth hormone-releasing peptide KP-102 induces c-fos ex..." RPEP-00368. Retrieved from https://rethinkpeptides.com/research/kamegai-1996-the-growth-hormonereleasing-peptide

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.